Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2013-08-07
Product name
Zoledronic Acid
Chemical name
(1-Hydroxy-2-imidazol-l-yl-phosphonoethyl) phosphonic acid
1.2.1 Relevant identified uses
Hypercalcemia of Malignancy, tumor induced hypercalcemia
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals, Inc
Section 2
SECTION 2: Hazards identification
Primary Physical and Health Hazards: May damage fertility or unborn child.
Principle Routes of Exposure
Skin and eye contact, ingestion, inhalation Signs & Symptoms of Exposure: Common adverse effects include nausea, vomiting, gastrointestinal irritation, fatigue, decreased red blood cell count (anemia), constipation, fever, shortness of breath (dyspnea) and bone pain. Chemical Listed as Carcinogen: NTP No IARC No OSHA No
Medical Conditions Generally Aggravated by Exposure
Pregnancy; pre-existing renal insufficiency; pre existing hypocalcemia; known hypersensitivity to zoledronic acid or any of the excipients. 2 of 7
